Cardiac amyloidosis
Would you like to receive a message when there is new research about cardiac amyloidosis? This is possible with an account. Create a free account or log in.
Automatically tracked from PubMed and ClinicalTrials.gov, newest on top. Nothing ever disappears here: what you keep in your favorites remains findable. · RSS feed of this disease · only the strongest evidence
Read in plain language what each study is about? With Premium, a single sentence appears above each publication explaining what was investigated — and you'll receive a notification as soon as new research on Cardiac Amyloidosis is available. View what Premium costs.
Publications and studies (1416)
- Diagnostic and Therapeutic Strategy for Female Patients With Cardiac Amyloidosis. (2021/11/11) ♡
- Diagnostic and Therapeutic Strategy for Female Patients With Cardiac Amyloidosis - Reply. (2021/11/11) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Diflunisal Targeted Delivery Systems: A Review. (2021/11/06) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Right Ventricular Endocardial Mapping and a Potential Arrhythmogenic Substrate in Cardiac Amyloidosis-Role of ICD. (2021/11/05) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Light Chain (AL) Cardiac Amyloidosis: A Diagnostic Dilemma. (2021/11/05) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. AA amyloidosis complicating monoclonal gammopathies, an unusual feature validating the concept of "monoclonal gammopathy of inflammatory significance"? (2021/11/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Performance of bone tracer for diagnosis and differentiation of transthyretin cardiac amyloidosis: a systematic review and meta-analysis. (2021/11/01) ♡
- Echocardiography and Nuclear Scintigraphy in the Diagnosis of Transthyretin Cardiac Amyloidosis. (2021/11/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Role of Cardiac Biomarkers in Cancer Patients. (2021/10/29) ♡
- High Serum Carbohydrate Antigen (CA) 125 Level Is Associated With Poor Prognosis in Patients With Light-Chain Cardiac Amyloidosis. (2021/10/28) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Genome silencer therapy leading to 'regression' of cardiac amyloid load on cardiovascular magnetic resonance: a case report. (2021/10/12) ♡
- Serial scanning with (99m)Tc-3, 3-diphosphono-1, 2-propanodicarboxylic acid ((99m)Tc-DPD) for early detection of cardiac amyloid deposition and prediction of clinical worsening in subjects carrying a transthyretin gene mutation. (2021/10/01) ♡
- Reproducibility and Repeatability of Assessment of Myocardial Light Chain Amyloidosis Burden Using (18)F-Florbetapir PET/CT. (2021/10/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. What is the optimal cardiac screening for asymptomatic transthyretin gene mutation carriers? (2021/10/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Reproducibility and repeatability of assessment of myocardial light chain amyloidosis burden using (18)F-florbetapir PET/CT. (2021/10/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Endoscopic diagnosis of chronic diarrhea. (2021/09/28) ♡
- Magnetic Resonance Imaging in Cardiac Amyloidosis: Unraveling the Stealth Entity. (2021/09/21) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Long-term effect of tocilizumab on left ventricular hypertrophy and systolic dysfunction in AA amyloidosis with rheumatoid arthritis. (2021/09/20) ♡
- Utility of Neuropathy Screening for Wild-Type Transthyretin Amyloidosis Patients. (2021/09/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Amyloid Cardiopathy and Aortic Stenosis. (2021/09/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Double Delayed Enhancement: Concomitant Cardiac Amyloidosis and Acute Coronary Embolism. (2021/08/26) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Management of complications of cardiac amyloidosis: 10 questions and answers. (2021/08/09) ♡
- Frailty in Wild-Type Transthyretin Cardiac Amyloidosis: The Tip of the Iceberg. (2021/07/31) ♡
- Corrigendum to: A new therapy for Transthyretin amyloidosis, no longer an orphan condition. (2021/07/18) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Transthyretin: From Structural Stability to Osteoarticular and Cardiovascular Diseases. (2021/07/13) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Successful management of refractory constipation using Kampo medicine Mashiningan in a patient with wild-type ATTR cardiac amyloidosis. (2021/07/03) ♡
- Experience of endomyocardial biopsy from a tertiary care center in India. (2021/07/01) ♡
- Global Left Ventricular Myocardial Work Efficiency in Heart Failure Patients with Cardiac Amyloidosis: Pathophysiological Implications and Role in Differential Diagnosis. (2021/07/01) ♡
- Incidence, Cause of Death, and Survival of Amyloidosis in Korea: A Retrospective Population-Based Study. (2021/06/28) ♡
- Diagnosing Transthyretin Cardiac Amyloidosis by Technetium Tc 99m Pyrophosphate: A Test in Evolution. (2021/06/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Recipe for Success in Transthyretin Cardiomyopathy: Monoclonal Protein Rule Out, SPECT Imaging, and Genetic Testing. (2021/06/01) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. New treatment for myocardial diseases. (2021/06/01) ♡
- Real-world outcomes in non-endemic hereditary transthyretin amyloidosis with polyneuropathy: a 20-year German single-referral centre experience. (2021/06/01) ♡
- Apolipoprotein AI amyloid deposits in the ligamentum flavum in patients with lumbar spinal canal stenosis. (2021/06/01) ♡
- Initial experience with percutaneous mitral valve repair in patients with cardiac amyloidosis. (2021/06/01) ♡
- Cardiac transthyretin amyloidosis (99m)Tc-DPD SPECT correlates with strain echocardiography and biomarkers. (2021/06/01) ♡
- Tenosynovial complications identify TTR cardiac amyloidosis among patients with hypertrophic cardiomyopathy phenotype. (2021/06/01) ♡
- Racial and Ethnic Disparities in Transthyretin Cardiac Amyloidosis. (2021/06/01) ♡
- Cerebrovascular insufficiency and amyloidogenic signaling in Ossabaw swine with cardiometabolic heart failure. (2021/05/24) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Preclinical diagnosis of wild-type transthyretin amyloid cardiomyopathy in a patient undergoing carpal tunnel release. (2021/05/21) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Increased device thresholds with subsequent improvement status post-systemic therapy in a patient with multiple myeloma. (2021/05/18) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Comparative pathological findings between coronary bare-metal stent implantation and balloon angioplasty over 16 years. (2021/05/17) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Radionuclide Imaging in the Diagnosis of Transthyretin Cardiac Amyloidosis: Different Sensitivity in Early-Onset V30M Mutation? (2021/05/01) ♡
- Meta-analysisiAll studies on one question combined and calculated together. This is the strongest form of research that exists: a single loose study can be coincidence, dozens together much less so. The label says something about the design, not about the outcome — which can also be that something does NOT work. Reference Ranges, Diagnostic and Prognostic Utility of Native T1 Mapping and Extracellular Volume for Cardiac Amyloidosis: A Meta-Analysis. (2021/05/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Prognostic value of right ventricular function in light-chain cardiac amyloidosis treated with bortezomib. (2021/05/01) ♡
- Prevalence of transthyretin amyloid cardiomyopathy in male patients who underwent bilateral carpal tunnel surgery: The ACTUAL study. (2021/04/15) ♡
- Review articleiA summary of what is known about a topic, written by experts. Not compiled according to fixed search rules, so the selection of studies may be biased. Cardiac amyloidosis: in search of the ideal diagnostic tool. (2021/04/01) ♡
- Description of individual patientsiThe story of one or a couple of patients. Informative, but you cannot infer from it whether something works in general. Value of SPECT imaging in patients with TTR-amyloid: ratios are not enough. (2021/04/01) ♡
- Posttreatment dFLC less than 10 mg/L predicts superior organ response and longer time to next treatment in newly diagnosed light-chain amyloidosis patients treated with bortezomib. (2021/04/01) ♡
- Commentary or editorialiAn expert's opinion or commentary, not new research. Daratumumab is safe and induces a rapid hematological response in light-chain amyloidosis with severe cardiac impairment. (2021/04/01) ♡
codex.care does not provide medical advice. Always discuss symptoms, medication, and treatment choices with your own healthcare provider.